ClinicalTrials.Veeva

Menu

Evaluation of Tetrix Cream as a Protective Barrier Against Injurious Materials

C

Coria Laboratories

Status

Completed

Conditions

Healthy

Treatments

Device: Tetrix

Study type

Interventional

Funder types

Industry

Identifiers

NCT00643630
806 805 09 002

Details and patient eligibility

About

To determine if Tetrix Cream,, when applied to the skin, acts as a barrier to prevent injury to the skin

Enrollment

36 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Normal subjects who are sensitized to nickel, neomycin, or fragrance mix.

Exclusion criteria

  • Under 18 years of age.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

36 participants in 2 patient groups, including a placebo group

1
Experimental group
Description:
Twice daily topical application
Treatment:
Device: Tetrix
Device: Tetrix
2
Placebo Comparator group
Description:
Twice daily topical application
Treatment:
Device: Tetrix
Device: Tetrix

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems